Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Ward

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Epidemics|September 11, 2022
The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemicMaria Piggin, Emma Smith, Peter Mankone, et al.
Nature Communications|February 17, 2022
Population antibody responses following COVID-19 vaccination in 212,102 individualsHelen Ward, Matthew Whitaker, Barnaby Flower, et al.
Health Technology Assessment (Winchester, England)|January 14, 2014
Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modellingChristian L Althaus, Katherine M E Turner, Catherine H Mercer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 2, 2020
Management of Fracture Risk in Patients with Chronic Obstructive Pulmonary Disease (COPD): Building a UK Consensus Through Healthcare Professional and Patient EngagementAyushman Gupta, Leah R Jayes, Steve Holmes, et al.
Wellcome Open Research|March 24, 2022
Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods studyCaroline Barker, Katharine Collet, Diane Gbesemete, et al.
The Lancet Regional Health. Europe|May 10, 2021
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adultsHelen Ward, Graham S Cooke, Christina Atchison, et al.
Science (New York, N.Y.)|April 24, 2021
Resurgence of SARS-CoV-2: Detection by community viral surveillanceSteven Riley, Kylie E C Ainslie, Oliver Eales, et al.
Journal of the Royal Society of Medicine|May 26, 2016
How would a decision to leave the European Union affect medical research and health in the United Kingdom?Azeem Majeed, Anna Hansell, Sonia Saxena, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Epidemics|September 11, 2022
The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemicMaria Piggin, Emma Smith, Peter Mankone, et al.
Nature Communications|February 17, 2022
Population antibody responses following COVID-19 vaccination in 212,102 individualsHelen Ward, Matthew Whitaker, Barnaby Flower, et al.
Health Technology Assessment (Winchester, England)|January 14, 2014
Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modellingChristian L Althaus, Katherine M E Turner, Catherine H Mercer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 2, 2020
Management of Fracture Risk in Patients with Chronic Obstructive Pulmonary Disease (COPD): Building a UK Consensus Through Healthcare Professional and Patient EngagementAyushman Gupta, Leah R Jayes, Steve Holmes, et al.
Wellcome Open Research|March 24, 2022
Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods studyCaroline Barker, Katharine Collet, Diane Gbesemete, et al.
The Lancet Regional Health. Europe|May 10, 2021
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adultsHelen Ward, Graham S Cooke, Christina Atchison, et al.
Science (New York, N.Y.)|April 24, 2021
Resurgence of SARS-CoV-2: Detection by community viral surveillanceSteven Riley, Kylie E C Ainslie, Oliver Eales, et al.
Journal of the Royal Society of Medicine|May 26, 2016
How would a decision to leave the European Union affect medical research and health in the United Kingdom?Azeem Majeed, Anna Hansell, Sonia Saxena, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Pageof 20